Literature DB >> 21945803

Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.

Hon Wai Koon1, David Q Shih, Tressia C Hing, Jeremy Chen, Samantha Ho, Dezheng Zhao, Stephan R Targan, Charalabos Pothoulakis.   

Abstract

We have shown that substance P (SP) and its neurokinin-1 receptor (NK-1R) regulate intestinal angiogenesis by increasing expression of protein CYR61 (the cysteine-rich angiogenic inducer 61, or CCN1) in colonic epithelial cells. However, the mechanism involved in SP-induced CCN1 expression has not been studied, and the outcome of increased CCN1 expression in the development of colitis is not fully understood. Because histone deacetylase (HDAC) modulates transcription of several genes involved in inflammation, we investigated participation of HDAC in SP-induced CCN1 expression in human colonic epithelial NCM460 cells overexpressing NK-1R (NCM460-NK-1R) and in primary colonocytes. SP increased HDAC activity with deacetylation and dephosphorylation of nucleosome protein histone H3 in NCM460-NK-1R and/or primary colonocytes. Histone deacetylation and dephosphorylation was observed in colonic mucosa from irritable bowel disease patients. Similarly, colonic mucosal tissues from mice exposed to dextran sulfate sodium showed histone H3 deacetylation and dephosphorylation and increased HDAC activity that was reversed by the NK-1R antagonist CJ-12255. SP-induced increased CCN1 expression in NCM460-NK-1R cells was abolished by pharmacological HDAC inhibition. HDAC overexpression activated basal and SP-induced CCN1 promoter activity. Intracolonic CCN1 overexpression significantly ameliorated dextran sulfate sodium-induced colitis, with reduction of proinflammatory cytokine expression in mice. Thus, SP-mediated CCN1 expression in the inflamed human and mouse colon involves increased HDAC activity. Our results strongly suggest that increased CCN1 expression may be involved in mucosal healing during colitis.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945803      PMCID: PMC3204086          DOI: 10.1016/j.ajpath.2011.07.038

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Neurobiology of substance P and the NK1 receptor.

Authors:  Patrick W Mantyh
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

2.  Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells.

Authors:  Zunxuan Chen; Steven Clark; Marian Birkeland; Chiu Mei Sung; Amparo Lago; Ronggang Liu; Robert Kirkpatrick; Kyung Johanson; James D Winkler; Erding Hu
Journal:  Cancer Lett       Date:  2002-12-15       Impact factor: 8.679

3.  Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P.

Authors:  M M Chang; S E Leeman
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

4.  Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor.

Authors:  I Castagliuolo; O Morteau; A C Keates; L Valenick; C-C Wang; J Zacks; B Lu; N P Gerard; C Pothoulakis
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).

Authors:  David R Brigstock
Journal:  Angiogenesis       Date:  2002       Impact factor: 9.596

Review 6.  Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.

Authors:  Irfan Rahman; John Marwick; Paul Kirkham
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

7.  Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes.

Authors:  Hon-Wai Koon; Dezheng Zhao; Xi Na; Mary P Moyer; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2004-08-19       Impact factor: 5.157

8.  CYR61 (CCN1) is essential for placental development and vascular integrity.

Authors:  Fan-E Mo; Andrew G Muntean; Chih-Chiun Chen; Donna B Stolz; Simon C Watkins; Lester F Lau
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus.

Authors:  Arthur F Stucchi; Khaled O Shebani; Susan E Leeman; Chi-Chung Wang; Karen L Reed; A Brent Fruin; Adam C Gower; James P McClung; Christopher D Andry; Michael J O'Brien; Charalabos Pothoulakis; James M Becker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-31       Impact factor: 4.052

Review 10.  The CCN family: a new stimulus package.

Authors:  D R Brigstock
Journal:  J Endocrinol       Date:  2003-08       Impact factor: 4.286

View more
  9 in total

Review 1.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

2.  Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.

Authors:  Hon Wai Koon; Jiani Wang; Caroline C Mussatto; Christina Ortiz; Elaine C Lee; Diana Hoang-Ngoc Tran; Xinhua Chen; Ciaran P Kelly; Charalabos Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.

Authors:  Yu Di; Yiou Zhang; Hongwei Yang; Aiyuan Wang; Xiaolong Chen
Journal:  Drug Des Devel Ther       Date:  2015-04-30       Impact factor: 4.162

Review 4.  Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease.

Authors:  Claudio Bernardazzi; Beatriz Pêgo; Heitor Siffert P de Souza
Journal:  Mediators Inflamm       Date:  2016-07-04       Impact factor: 4.711

5.  CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway.

Authors:  Chunlan Xu; Sally Ghali; Jiani Wang; David Q Shih; Christina Ortiz; Caroline C Mussatto; Elaine C Lee; Diana H Tran; Jonathan P Jacobs; Venu Lagishetty; Phillip Fleshner; Lori Robbins; Michelle Vu; Tressia C Hing; Dermot P B McGovern; Hon Wai Koon
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

Review 6.  Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.

Authors:  Lorenz Gerbeth; Rainer Glauben
Journal:  Front Med (Lausanne)       Date:  2021-03-26

7.  Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells.

Authors:  Yeonsil Yu; Se-Young Oh; Ha Yeong Kim; Ji-Young Choi; Sangmee Ahn Jo; Inho Jo
Journal:  Cells       Date:  2022-02-03       Impact factor: 7.666

8.  MiR-21 in Substance P-induced exosomes promotes cell proliferation and migration in human colonic epithelial cells.

Authors:  Kyriaki Bakirtzi; Ivy Ka Man Law; Kai Fang; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.871

Review 9.  The Interplay between Nutrition, Innate Immunity, and the Commensal Microbiota in Adaptive Intestinal Morphogenesis.

Authors:  Franziska Bayer; Olga Dremova; My Phung Khuu; Könül Mammadova; Giulia Pontarollo; Klytaimnistra Kiouptsi; Natalia Soshnikova; Helen Louise May-Simera; Kristina Endres; Christoph Reinhardt
Journal:  Nutrients       Date:  2021-06-26       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.